2019
DOI: 10.1016/j.jinorgbio.2019.110768
|View full text |Cite
|
Sign up to set email alerts
|

Hydroxyquinoline-derived anticancer organometallics: Introduction of amphiphilic PTA as an ancillary ligand increases their aqueous solubility

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 35 publications
(19 citation statements)
references
References 52 publications
0
19
0
Order By: Relevance
“…Both enantiomers were found in the molecular structures which were overall very similar to those of the analogous complexes with hexafluorophosphate as the counterion ( Table 1 ). The M–Cp* centroid distance in 2a Cl , however, was significantly shorter than found for the Cp* complexes [ 43 ].…”
Section: Resultsmentioning
confidence: 99%
“…Both enantiomers were found in the molecular structures which were overall very similar to those of the analogous complexes with hexafluorophosphate as the counterion ( Table 1 ). The M–Cp* centroid distance in 2a Cl , however, was significantly shorter than found for the Cp* complexes [ 43 ].…”
Section: Resultsmentioning
confidence: 99%
“…One of the most prominent compounds is the Ga(III) complex of HQ (tris(8-quinolinolato)gallium, KP46), which had successfully entered clinical trials and it was effective against renal cancer [23]. HQ and its derivatives also form complexes with Ru(η 6 -p-cymene) (RuCym) and Rh(η 5 -C 5 Me 5 ) (RhCp*) characterized by high solution stability, and many of them were reported to display potent anticancer activity in human cancer cell lines [7][8][9][24][25][26][27].…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, research on cyclometalated rhodium complexes has largely focused on non‐cyclopentadienyl cyclometalated rhodium complexes that target DNA, enzyme or protein–protein interfaces , , . Reported cyclopentadienyl rhodium anticancer complexes to date, have mainly contained N ^ N,, N ^ S, N ^ O, or O ^ O, , chelating ligands.…”
Section: Introductionmentioning
confidence: 99%